Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
35,208,390
-
Share change
-
+170,233
-
Total reported value
-
$185,094,881
-
Put/Call ratio
-
10%
-
Price per share
-
$5.26
-
Number of holders
-
31
-
Value change
-
+$787,443
-
Number of buys
-
7
-
Number of sells
-
14
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q2 2024
As of 30 Jun 2024,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,208,390 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Soleus Capital Management, L.P., MORGAN STANLEY, PFM Health Sciences, LP, RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, Rhenman & Partners Asset Management AB, and Rock Springs Capital Management LP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.